Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Wade Ackerman
Partner
Los Angeles +1 424 332 4763 ackermanw@cov.com Download V-card

Through more than a decade of experience in private practice and positions within the FDA and on the Hill, Wade Ackerman has acquired unique insights into the evolving legal and regulatory landscape facing companies marketing FDA-regulated products. Mr. Ackerman advises clients on FDA regulatory matters across a range of sectors, including drugs and biologics, cosmetics, medical devices and diagnostics, and digital health products and services associated with drugs and traditional devices. He serves as one of the leaders of Covington’s multidisciplinary Digital Health Initiative, which brings together the firm’s considerable resources across the broad array of legal, regulatory, commercial, and policy issues relating to the development and marketing of digital health technologies.

Previous Experience

  • U.S. Senate Committee on Health, Education, Labor, and Pensions, Senior FDA Counsel
  • U.S. Food and Drug Administration, Associate Chief Counsel
  • Named one of the most influential diverse lawyers in Los Angeles by the Los Angeles Business Journal (2018).
  • Legal 500 US, Health Care - Life Sciences (2017)